P3 Health Partners Q2 revenue up 15% to $379.2M; net loss widens to $28.8M

P3 Health Partners Inc.

2024-Q2 EPS reported -$0.30 revenue$767,645,000

Total revenue $379.2M (+15% YoY); capitated revenue $374.3M (+15% YoY).
Gross profit $14.0M (down from $26.8M); medical margin $41.1M (down from $50.5M).
Net loss $28.8M (vs $27.6M); Adjusted EBITDA loss $8.8M (vs +$0.2M).
FY2024 guidance: revenue $1.45-$1.55B; medical margin $230-$250M; Adjusted EBITDA $20-$40M.
CEO cites top-line growth and balance sheet improvement from capital raise.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.